3D BIOPRINTING AND THE FUTURE OF ORGAN TRANSPLANTATION: OPPORTUNITIES AND ETHICAL CHALLENGES
Abstract
Organ transplantation has been one of the most significant achievements of modern medicine, saving millions of lives each year. However, the global shortage of donor organs continues to be a pressing crisis, with more than 100,000 people currently on waiting lists in the United States alone and many thousands more worldwide. 3D bioprinting has emerged as a revolutionary technology with the potential to address this shortage by enabling the fabrication of living tissues and functional organs using biomaterials and patient-derived stem cells. This paper explores the principles of 3D bioprinting, its global advancements, potential applications in regenerative medicine, ethical challenges, and the prospects for its integration into healthcare systems. Additionally, the role of Uzbekistan and other developing countries in adapting and advancing this technology is considered.
Keywords
3D bioprinting, organ transplantation, regenerative medicine, biomaterials, ethical challenges, healthcare innovation
References
- World Health Organization (WHO). (2022). Global Observatory on Donation and Transplantation.
- U.S. Organ Procurement and Transplantation Network. (2023). Annual Report.
- Murphy, S. V., & Atala, A. (2014). 3D bioprinting of tissues and organs. Nature Biotechnology, 32(8), 773–785.
- Ozbolat, I. T. (2016). 3D bioprinting: Fundamentals, principles and applications. Academic Press.
- Ministry of Health of the Republic of Uzbekistan. (2022). Organ Transplantation Data.
- Karimova, D., & Ismoilova, N. (2021). Innovations in Transplant Medicine in Uzbekistan. Tashkent: Medical Publishing House.